Clinical Trial Finder

Back to the Clinical Trial Finder

Observational Closed to Enrollment

GI symptoms observational study (GALAXY) (GALAXY-OB-18)

This study will collect information on gastrointestinal (GI) symptoms that people with CF experience.

 This study will require a single visit where participants will enroll in the study and take four questionnaires. Participants will take these questionnaires at three different times outside the clinic. Researchers will evaluate the results to learn about CF GI symptoms and treatment.

Eligibility

  • Age:

    2 Years and Older

  • Mutation(s):

    No Mutation Requirement

  • FEV1% Predicted:

    No FEV1 Limit

For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.

Study Design

  • Study Type: ?more info

    Observational

  • Randomized Study: ?more info

    No

  • Placebo Controlled: ?more info

    No

  • Length of Participation:

    29 days

  • Number of Study Visits:

    1

Additional Information

  • Phase: ?more info

    Not Applicable

  • Study Sponsor: ?more info

  • Study Drugs:

    N/A

Study Sites

  • Closed to Enrollment

    California

    Stanford University Medical Center, Palo Alto, CA 94304

  • Closed to Enrollment

    Connecticut

    Central Connecticut Cystic Fibrosis Center, Hartford, CT 06106

  • Closed to Enrollment

    District of Columbia

    Children's National Medical Center, Washington, DC 20010

  • Closed to Enrollment

    Florida

    All Children's Hospital, St. Petersburg, FL 33701

  • Closed to Enrollment

    Florida

    Nemours Children's Clinic - Pensacola, Pensacola, FL 32514

  • Closed to Enrollment

    Georgia

    Children’s Healthcare of Atlanta and Emory University, Atlanta, GA 30322

  • Closed to Enrollment

    Illinois

    Northwestern University, Chicago, IL 60611

  • Closed to Enrollment

    Illinois

    OSF Saint Francis Medical Center, Peoria, IL 61637

  • Closed to Enrollment

    Indiana

    Riley Hospital for Children, Indianapolis, IN 46202

  • Closed to Enrollment

    Kentucky

    University of Kentucky, Lexington, KY 40506

  • Closed to Enrollment

    Maine

    Maine Medical Center, Portland, ME 04102

  • Closed to Enrollment

    Massachusetts

    University of Massachusetts Memorial Health Care, Worcester, MA 01655

  • Closed to Enrollment

    Massachusetts

    Boston Children's Hospital, Brigham & Women's Hospital, Boston, MA 02115

  • Closed to Enrollment

    Michigan

    Helen DeVos Children's Hospital, Grand Rapids, MI 49503

  • Closed to Enrollment

    Minnesota

    The Minnesota Cystic Fibrosis Center, Minneapolis, MN 55455

  • Closed to Enrollment

    Missouri

    SSM Health Cardinal Glennon Children’s Hospital, St. Louis, MO 63104

  • Closed to Enrollment

    New Jersey

    Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ 08903

  • Closed to Enrollment

    North Carolina

    Wake Forest University Baptist Medical Center, Winston-Salem, NC 27103

  • Closed to Enrollment

    North Carolina

    Atrium Health Pulmonary Care, Charlotte, NC 28203

  • Closed to Enrollment

    Ohio

    Nationwide Children's Hospital, Columbus, OH 43205

  • Closed to Enrollment

    Oklahoma

    Oklahoma Cystic Fibrosis Center, OKC, OK 73104

  • Closed to Enrollment

    Oregon

    Oregon Health Sciences University, Portland, OR 97239

  • Closed to Enrollment

    Pennsylvania

    Children's Hospital of Philadelphia, Philadelphia, PA 19104

  • Closed to Enrollment

    Texas

    University of Texas Southwestern / Children’s Health, Dallas, TX 75247

  • Closed to Enrollment

    Utah

    Primary Children's Cystic Fibrosis Center, Salt Lake City, UT 84113

  • Closed to Enrollment

    Vermont

    University of Vermont Medical Center, Burlington, VT 05401

Eligibility

  • Age:

    2 Years and Older

  • Mutation(s):

    No Mutation Requirement

  • FEV1% Predicted:

    No FEV1 Limit

For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.

Clinical Studies 101

  • Questions to Ask When Considering a Specific Trial

    Clinical trials that test potential drugs and therapies in people with cystic fibrosis are a major part of CF research. They take place at Cystic Fibrosis Foundation-accredited care centers all over the United States and enroll people with CF of all ages.

  • Patient Safety Is a Priority

    Nothing is more important than patient safety in developing new treatments for cystic fibrosis. The U.S. government requires that all clinical trials are supervised for safety, and the Cystic Fibrosis Foundation adds additional measures to protect study volunteers.

  • How Do Clinical Trials Work

    Each clinical trial has a study sponsor and a protocol. Potential drugs must move through four well-defined phases of testing in patients.

     

Sign up for clinical trial alerts

Get email updates about clinical trials that matter to you.

Check the Drug Development Pipeline

We’re attacking CF from every angle. Learn about the status of CF drugs in development.

Learn More